Resp Flashcards
IL4 vs IL5 ?
il4 - release IgE which stimulate mast cells to release histamine, luekotrienes
il5 - eosinophils = toxic proteins released
sever copd criteria?
GOLD classfication
FEV1 <30%
ratio < 0.7
also MRC dysnopnea scale is used!
BRONCHITIS dx?
chronic cough with sputum for at least 3 months in 2 consecutive years
FVC in COPD?
FEV1
fev1:fvc ratio
TLC
fvc lowered
fev1 lowered more than fvc
ratio low
tlc higher due to trapped air
signs of COPD?
fast shallow breathing
barrel chest
drum like sound on percussion
cyanosis
tar color on fingers
downward dysplacement of liver
severe gold classification copd ?
30% - 50% FEV1
ratio < 0.7
complications of COPD?
pulomonary hypertension
pneumothorax
resp failure
COR PULMONALE
resp failure type 1 vs type 2 ?
normal pCO2 low O2
type 1
raised pCO2 low O2
type 2
spirometry in asthma?
normal usually
as it varies day to day
types of asthma?
allergic (70%) - IgE mediated - hygiene hypothesis
non allergic (30%) - smoking
samters triad
nasal polyps
asthma
aspirin sensivity
does pharmacological tx improve copd life time?
doesn’t improve lung functions just symptom relief
sputum of asthma what could be shown?
lexton charcot crystals
cushmans spirals
life threatening asthma criteria?
PEF < 33%
MODERATE 50 - 75 %
bronchodilator effect on asthma vs copd?
asthma reversible effect - >12% FEV1
COPD irreversible - <12% FEV1
ddx copd
pneumonia
PE
hf
PNEUMOTHORAX
tx for copd algortyhm?
chronic algorithim +16
1st line SABA
2. SABA + ICS - check complience and techniques
3. SABA + ICS + LTRA
4. SABA + ICS + LABA +/- LTRA
5. INCREASE ICS DOSE
FENO asthma?
fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.
dx of asthma?
increased FENO
FEV1/ FVC < 0.7
FEV1 reversible with bronchodilator ]
LTRA stand for?
leukotrene receptor antagonist
muscarin inhibitor - prevents contriction
LAMA is also muscarinic antagonist
ICS example?
clenil modulite
LABA example?
salmeterol
MAB medication?
resiluzamab - monoclonal antibody treatment
Natalizumab - MS tx
- nib what type of medication?
kinase inhibitor nintedanib - tx for idiopathic pulmonary fibrosis
main advantage of nebulisers?
- THEIR MAIN ADVANTAGE IS THAT NO COORDINATION IS REQUIRED BY THE USER, AND HIGH DOSES OF DRUG CAN BE DELIVERED TO THE AIRWAYS.
when to use corticosteroids in COPD?
last resort
COPD patients are usually resistant!
- COPD: MOST PATIENTS ARE RESISTANT TO ICS. RESPONSIVE PATIENTS ARE THOUGHT TO HAVE CONCOMITANT ASTHMA WHICH MAY EXPLAIN THE ELEMENT OF SENSITIVITY TO ICS.
ICS and beta agonists ?
benefit eachother!
GLUCOCORTICOIDS INCREASE THE TRANSCRIPTION OF THE B2-RECEPTOR GENE, RESULTING IN
INCREASED EXPRESSION OF CELL SURFACE RECEPTORS = ICS HELP BETA AGONISTS TO WORK
tx for bronchoiectasis ? what has limited effect?
- ANTIBIOTICS TREAT INFECTIVE ELEMENTS OF BRONCHIECTASIS, PHYSICAL THERAPY CLEARS AIRWAYS. SURGERY AND TRANSPLANTATION FOR SEVERE DISEASE
- STRATEGIES AIM TO REDUCE SYMPTOMS RATHER THAN UNDERLYING CAUSE OF DISEASE
- MUCOLYTICS TREAT HYpERSECRETION
- B2AGONISTS MOST USEFUL IN COPD/ASTHMA/BRONCHIECTASIS OVERLAP SYNDROMES
- ANTICHOLINERGICS HAVE LIMITED EFFECT * ICS HAVE LIMITED EFFECT
what is the interstitium ?
area between alveolus and blood vessel
interstitial lung disease examples?
idiopathic pulmonary fibrosis, interstitial pneumonia and hypersensitivity pneumonitis
pathophysiology of ipf?
IPF IS AN EPITHELIAL-DRIVEN DISEASE WHEREBY AN ABERRANTLY ACTIVATED LUNG EPITHELIUM PRODUCES MEDIATORS OF FIBROBLAST MIGRATION, PROLIFERATION AND DIFFERENTIATION INTO ACTIVE MYOFIBROBLASTS.
THESE MYOFIBROBLASTS SECRETE EXAGGERATED AMOUNTS OF EXTRACELLULAR MATRIX (ECM) THAT SUBSEQUENTLY REMODEL THE LUNG ARCHITECTURE.
too much collagen = honeycomb formation!
DRUGS THAT slow progression if IPF?
PIRFENIDONE AND NINTEDANIB
surgery is often best option
how to distinuigish mestholioma from other tumours?
high production of calretinin
role of plueral cavity?
lubrication for expansion and contraction of lungs
how is fluid removed from pluera?
lymphatic drainage
lymphatic plueral effusion?
chylothorax
thoracic duct distrupted
- damage from surgery
- tumour in mediasteinum
lymphatic fluid accumulicates in plueral space
symptoms of plueral effusion?
SOB lying down
pain on inhalation
asymptomatic if small
dx of plueral effusion?
dullness of percussionn
decrased breath sounds
decreased tactile fremitus - vibration when talking
cxr - blurring of costophrenic angle when standing
lying down - layering effect
transudative fluid/ exudative fluid vs lymphatic fluid from plueral effusion drainage?
transudative - clear
exudative - cloudy
lympathtic - milky
common location of adenocarcinoma?
peripheral lung within mucus secreting glandular epithlium
most common cause of secondary hypertrophic osteoartheropathy? signs of this ?
adenocarcinoma
triad
clubbing
athritis
bone sweelinnng
‘onion skin’ appearance
common cause of hypertrophic pulmonary osteoartheropathy?
squamous cell non small cell carcinoma
where does squamous cell carcinoma arise from and located?
risk factor - smoking
central lung from lung epihtlium
sign of sqaumous cell carcinoma?
PTHrP may secrete hypercalcemia
hyperparathyroidism
signs of bronchial carcinoma? (small cell and NCC)
Cachexia
Finger Clubbing
Hypertrophic pulmonary osteoarthropathy
Anaemia
Horner’s syndrome (if the tumour is apical)
Examination of the chest: consolidation (pneumonia); collapse (absent breath sounds, ipsilateral tracheal deviation); pleural effusion (Stony dull percussion, decreased vocal resonance and breath sounds)
Enlargement of supraclavicular and axillary lymph nodes
Haemoptysis
COUGHING up blood
symptom of bronchial cancer